The mission of the Oregon Center for Complementary and Alternative Medicine and Neurological Disorders (ORCCAMIND) is to facilitate research and education on the effectiveness and mechanisms of action of complementary and alternative medicine (CAM) therapies in the treatment of neurological disorders. The integration of conventional medicine and CAM communities is critical for the success of ORCCAMIND. Thus, ORCCAMIND is composed of six institutions: Oregon Health Sciences University; National College of Naturopathic Medicine; Western States Chiropractic College; Oregon College of Oriental Medicine; the Linus Pauling Institute at Oregon State University; and the Portland Veteran Affairs Medical Center. ORCCAMIND will initially focus on the use of CAM antioxidants and stress reduction as treatments for neurodegenerative and demyelinating diseases because many of these diseases have oxidative injury as a causative or contributory factor and several CAM approaches have direct or indirect anti-oxidant effects. Through the Career Development Program, the Developmental Research Program and the activities of the Education and Information Core, we will also foster and promote research into other CAM approaches for neurologic diseases that extend beyond anti-oxidant therapies. ORCCAMIND will achieve its goals by carrying out 4 Research Projects and maintaining 4 Core facilities that integrate the research strengths of conventional medicine and CAM practitioners and researchers. ORCCAMIND draws it strength from the multi- institutional support and the quality of all its investigators. The investigators join ORCCAMIND with extensive experience with clinical trials, patient care, externally funded basic and clinical neuroscience research, and training programs, including federally-funded training grants. ORCCAMIND is a bold initiative that integrates basic and clinical research scientists, conventional neurologists and CAM practitioners. It will promote the exploration of CAM research and lead research on CAM therapies for neurological disorders.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Specialized Center (P50)
Project #
3P50AT000066-02S1
Application #
6451329
Study Section
Special Emphasis Panel (ZRG1 (22))
Program Officer
Pearson, Nancy
Project Start
1999-09-30
Project End
2004-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
2
Fiscal Year
2001
Total Cost
$4,172
Indirect Cost
Name
Oregon Health and Science University
Department
Neurology
Type
Schools of Medicine
DUNS #
009584210
City
Portland
State
OR
Country
United States
Zip Code
97239
Soumyanath, Amala; Zhong, Yong-Ping; Henson, Edward et al. (2012) Centella asiatica Extract Improves Behavioral Deficits in a Mouse Model of Alzheimer's Disease: Investigation of a Possible Mechanism of Action. Int J Alzheimers Dis 2012:381974
Salinthone, Sonemany; Schillace, Robynn V; Tsang, Catherine et al. (2011) Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms. J Nutr Biochem 22:681-90
Howieson, Diane B; Mattek, Nora; Seeyle, Adriana M et al. (2011) Serial position effects in mild cognitive impairment. J Clin Exp Neuropsychol 33:292-9
Dodge, Hiroko H; Katsumata, Yuriko; Todoriki, Hidemi et al. (2010) Comparisons of plasma/serum micronutrients between Okinawan and Oregonian elders: a pilot study. J Gerontol A Biol Sci Med Sci 65:1060-7
Elsas, S-M; Rossi, D J; Raber, J et al. (2010) Passiflora incarnata L. (Passionflower) extracts elicit GABA currents in hippocampal neurons in vitro, and show anxiogenic and anticonvulsant effects in vivo, varying with extraction method. Phytomedicine 17:940-9
Yadav, Vijayshree; Shinto, Lynne; Bourdette, Dennis (2010) Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Rev Clin Immunol 6:381-95
Shinto, L; Marracci, G; Baldauf-Wagner, S et al. (2009) Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis. Prostaglandins Leukot Essent Fatty Acids 80:131-6
Tian, Wei; Fu, Yi; Garcia-Elias, Anna et al. (2009) A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci U S A 106:14034-9
Dodge, H H; Zitzelberger, T; Oken, B S et al. (2008) A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology 70:1809-17
Salinthone, Sonemany; Yadav, Vijayshree; Bourdette, Dennis N et al. (2008) Lipoic acid: a novel therapeutic approach for multiple sclerosis and other chronic inflammatory diseases of the CNS. Endocr Metab Immune Disord Drug Targets 8:132-42

Showing the most recent 10 out of 33 publications